Difference between revisions of "Profiles"

From QIBA Wiki
Jump to navigation Jump to search
Line 33: Line 33:
 
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]] (open for public comment until EOB April 5th)
 
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]] (open for public comment until EOB April 5th)
  
 +
*[[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| Atherosclerosis Biomarkers by (C)CTA - 2019 Imaging Profile 2019-02-26]] (open for public comment until EOB June 3rd)
  
 
'''[[Comment Resolutions]] for Past Public Comments''' will be posted.
 
'''[[Comment Resolutions]] for Past Public Comments''' will be posted.

Revision as of 14:40, 1 April 2019

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Profiles may be of use at any Stage.

Stage 3: Technically Confirmed Profiles


Stage 2: Consensus Profiles


Stage 1: Public Comment Profiles

Please submit comments using the online form

Comment Resolutions for Past Public Comments will be posted.

Format for Citing Profiles

Cite QIBA Profile documents as:

Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL

Example:

QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles

Statements of Endorsement


See Also

Retrieved from "https://qibawiki.rsna.org/index.php?title=Profiles&oldid=13950"